News
Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, targeting the ...
The global health community faces a deepening challenge—not only from infectious diseases but also from a pandemic of ...
There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.
Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...
Robert F. Kennedy Jr. announces plans to reform the Vaccine Injury Compensation Program, addressing claims of inefficiency ...
1d
Barchart on MSN1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year
Moderna (MRNA), once an unknown biotech firm, quickly rose to the top of the global vaccine market during the COVID-19 ...
CEO Rob Davis referred to the cost reduction program as a 'reallocation' rather than a cut, with the savings to be reinvested ...
1d
Zacks Investment Research on MSNModerna to Report Q2 Earnings: Is a Beat in Store for the Stock?
We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...
Updated Vaccine Recommendations Earlier this week, Secretary Kennedy announced in a social media video that the recommendation for COVID vaccination of a "pregnant woman has been removed from the ...
The seeds of a court case that has lasted for more than 20 years were planted in February 2001, when the parents of ...
Today, anthrax remains one of the deadliest and easiest biological weapons to produce. Yet 80 percent of the U.S. supply of ciprofloxacin is still imported. Moreover, most of those imports, whether ...
Federal liability protections currently prevent people suing COVID-19 vaccine makers, and instead require them to request ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results